$17.01
1.85% day before yesterday
NYSE, Dec 27, 10:00 pm CET
ISIN
US1638511089
Symbol
CC

Chemours Co. Stock price

$17.01
-4.81 22.04% 1M
-6.08 26.33% 6M
-14.53 46.07% YTD
-15.46 47.61% 1Y
-15.55 47.76% 3Y
-0.61 3.46% 5Y
-3.84 18.42% 10Y
NYSE, Closing price Fri, Dec 27 2024
-0.32 1.85%
ISIN
US1638511089
Symbol
CC

Key metrics

Market capitalization $2.54b
Enterprise Value $6.22b
P/E (TTM) P/E ratio 37.18
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.08
P/S ratio (TTM) P/S ratio 0.44
P/B ratio (TTM) P/B ratio 3.87
Dividend yield 5.88%
Last dividend (FY24) $1.00
Revenue growth (TTM) Revenue growth -4.23%
Revenue (TTM) Revenue $5.75b
EBIT (operating result TTM) EBIT $377.00m
Free Cash Flow (TTM) Free Cash Flow $-673.00m
Cash position $616.00m
EPS (TTM) EPS $0.46
P/E forward 14.16
P/S forward 0.44
EV/Sales forward 1.08
Short interest 7.26%
Show more

Is Chemours Co. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Chemours Co. Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Chemours Co. forecast:

5x Buy
45%
5x Hold
45%
1x Sell
9%

Analyst Opinions

11 Analysts have issued a Chemours Co. forecast:

Buy
45%
Hold
45%
Sell
9%

Financial data from Chemours Co.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
5,750 5,750
4% 4%
100%
- Direct Costs 4,625 4,625
2% 2%
80%
1,125 1,125
12% 12%
20%
- Selling and Administrative Expenses 342 342
63% 63%
6%
- Research and Development Expense 109 109
3% 3%
2%
674 674
184% 184%
12%
- Depreciation and Amortization 297 297
3% 3%
5%
EBIT (Operating Income) EBIT 377 377
639% 639%
7%
Net Profit 69 69
122% 122%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Chemours Co. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Chemours Co. Stock News

Neutral
Business Wire
15 days ago
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Announces Completion of Euro denominated Term Loan Repricing.
Neutral
Business Wire
19 days ago
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--PCC Group plans to build and operate a state-of-the-art chlor-alkali facility at Chemours' DeLisle, MS Titanium Dioxide Plant.
Neutral
Business Wire
29 days ago
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Announces Completion of U.S. Dollar-denominated Term Loan Repricing.
More Chemours Co. News

Company Profile

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. It operates through the following segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment produces titanium dioxide. The Fluoroproducts segment supplies refrigerants and industrial fluoropolymer resins. The Chemical Solutions segment provides chemicals used in gold production, oil refining, agriculture, and industrial polymers. The firm offers refrigerants, industrial fluoropolymer resins, sodium cyanide, performance chemicals and intermediates, and titanium dioxide pigments to the plastics and coatings, refrigeration and air conditioning, general industrial, electronics, mining, and oil refining markets. The company was founded on February 18, 2014 and is headquartered in Wilmington, Delaware.

Head office United States
CEO Denise Dignam
Employees 6,200
Founded 2014
Website www.chemours.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today